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ABSTRACT
Objective: This study was focused on an evaluation of antimicrobial activity of actinobacteria isolated from Kanyakumari marine sediments.
Methods: This study includes sample collection from Kanyakumari beach, followed by isolation of marine Actinobacteria, screening for antibacterial 
activity and antifungal activity. Finally, the most active isolate was identified using 16S rRNA sequencing.
Results: Marine Actinobacteria are one of the leading microbes of the ocean known for producing excellent secondary metabolites and having a 
broad spectrum of antimicrobial activity; hence, they are very important from an industrial point of view. The marine sediment sample used was 
collected from Kanyakumari beach, in the month of July, falling in the latitudinal range of 8.5074°N and in the longitude of 76.9730°E. A total of eight 
actinobacterial colonies were isolated by spread plate technique on Actinomycetes isolation agar, Kuster’s agar, and starch casein agar. The isolate 
cultures were designated as UST1-UST8. Among them, UST3 showed a maximum zone of inhibition against clinical pathogens Salmonella typhi and 
Aspergillus niger with a zone of inhibition of 22 mm and 20 mm, respectively. In solvent extraction study, ethyl acetate and hexane was found as 
best solvents for extraction. Potential isolate UST3 was identified as Streptomyces variabilis using morphological studies and 16S rRNA sequencing. 
Potential strain was submitted as S. variabilis-VITUMVB03.
Conclusion: Results obtained in this study concluded that marine Actinobacteria have broad-spectrum antimicrobial activity and can be used in the 
pharmaceutical industry.
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INTRODUCTION
More than 75% of our earth surface is covered with water, of which 
major parts comes under marine environment. Marine environment 
is already proven as a rich source for the production of bioactive 
compounds [1]. Among the bioactive compound producing organisms 
present in marine environments, Actinobacteria were found as the most 
potent group microorganisms producing a large variety of bioactive 
compounds such as antifungal, antibacterial, antioxidant, and antiviral 
agents [2]. Marine Actinobacteria are the most inventive producers 
of bioactive compounds. These highly active Actinobacteria have 
applications not only medical field but also have shown their potential 
in various other fields such as agriculture and various industries [3]. 
Actinobacteria are spore producing Gram-positive bacteria with high 
G+C content in their DNA [4]. Marine Actinobacteria, when compare 
with terrestrial Actinobacteria are highly active, can produce 
different types of bioactive compounds and also have differences in 
their characteristics. These differences are due to the harsh marine 
environmental condition of marine Actinobacteria [5]. Most marine 
Actinobacteria of medical and economical applications comes under 
the subclass Actinobacteridae. In this subclass marine Streptomyces sp. 
are known as a source for the production of 60-70% of antibiotics. 
Most of the secondary metabolites that are used as antibacterial, 
antifungal, antiviral, antithrombotic, antitumor, and enzyme inhibitors 
are produced by Streptomyces sp. [6-8]. Furthermore, few available 
insecticides, herbicides, fungicides, and growth promoting substances 
for animals and plants are synthesized using marine Streptomyces.
After the discovery of penicillin and streptomycin antibiotics, many 
researchers felt the importance and need for the discovery of new 
drugs. Related to that importance various organisms were tested for 
their ability to produce antimicrobial compounds. Among all tested 
microorganisms marine Actinobacteria stood out as potential producers 
of many antimicrobial and antitumor compounds [9,10]. Antibacterial 
compounds produced from chemical means are very efficient in 
controlling many infections and diseases, but these bacterial pathogens 
are soon getting resistant to these drugs [11]. Therefore, at present, 
synthesis of naturally or biologically synthesized bioactive compounds 
are needed. In this case, marine Actinobacteria are seen as the most 
promising source. Most of these organisms show a broad spectrum 
activity, for example, bonactin drug isolated from Streptomyces sp. 
possess very good antifungal and antibacterial activity [12]. Similarly, 
marinomycin drug produced from Marinispora sp. have shown good 
antifungal and anticancer activities [13]. In the present world, fungal 
disease is on raise when compared with bacterial disease since fungal 
disease are difficult to treat due to the similarity in the mammalian and 
fungal cell structures [14]. Marine Actinobacteria are also viewed for its 
ability as a potential antifungal agent. Commercially available antifungal 
drugs such as neomycin, griseofulvin, and polyene antimycotics are used 
as applicants and cannot be taken orally. Hence for the production of 
oral drug with least side effects for fungal disease marine Actinobacteria 
has been tested [15]. Various conducted tests proved that marine 
Actinobacteria can be used as a useful biological tool for the production 
of antifungal drugs against pathogenic fungi [16]. Recently, antifungal 
activity of highly biocompatible form chitinase and its derivatives that 
are used in biomedical fields such as wound healing, cartilage tissue 
engineering, drug delivery, and nerve generation are synthesized by 
marine Actinobacteria [17-19]. N-(2-hydroxyphenyl)-2-phenazinamine 
is a new and active antibiotic isolated from Nocardia dassonvillei which 
showed significant antifungal activity against C. albicans [19,20]. Hence, 
this study was focused on antibacterial and antifungal activities of 
marine Actinobacteria isolated Kanyakumari marine sediments.
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METHODS
Chemicals and media
All the chemicals and media used in this study were purchased from 
HiMedia Laboratory Pvt. Ltd., Mumbai.
Sample collection
The marine sediments were collected from the Kanyakumari beach 
(8.5074°N, 76.9730°E), Tamil Nadu, India. Samples were collected 
from at a depth of 10-15 cm from the topmost layer and aseptically 
transferred into sterile bags. All samples were then transferred to 
microbiology laboratory and stored at 4°C for further studies.
Isolation of Actinobacteria
Isolation of marine Actinobacteria from the collected sample was done 
using Actinomycetes isolation agar, starch casein agar, and Kuster’s 
agar by spread plate technique by using 50% of marine water. All 
plates were supplemented with a small amount of nalidixic acid and 
potassium dichromate to avoid both bacterial and fungal contamination, 
respectively. All plates were then incubated at room temperature 
for 5-7 days. Plates were checked for powdery and leathery colonies 
followed by isolation, purification and storage at 4°C for further use [21].
Clinical culture
Bacterial pathogens and fungal pathogens such as Escherichia coli, 
Klebsiella pneumoniae, Staphylococcus aureus, Salmonella typhi, 
Aspergillus flavus, and Aspergillus niger were collected from Narayani 
Hospital, Sripuram, Vellore, Tamil Nadu.
Fermentation media
All eight isolates were separately inoculated in 100 ml production 
media (soluble starch, glucose, yeast extract, trace elements, and 
distilled water) in a 250 ml conical flask at 37°C in a shaker for 7 days 
at 120 rpm. After incubation period, all flasks were centrifuged at 
1000 rpm for 15 minutes and supernatant was collected to carry of 
bioactive activities.
Antimicrobial activity
Antibacterial activity of actinobacterial isolates
Agar well diffusion method was used to determine the antibacterial 
activity of the crude extract. Using a sterile gel borer 6 mm diameter of the 
well was made on agar media. Inoculums of clinical pathogens (0.1 ml) 
were spread on the plates, and 100 µl of crude extract (20-200 µg/ml) 
was loaded in different wells to evaluate their activity against clinical 
pathogens such as S. aureus, E. coli, S. typhi, and K. pneumoniae. Plates 
were incubated for 24 hrs at 37°C. After 24 hrs, plates were checked for 
zone of inhibition [22,23].
Antifungal activity of actinobacterial isolates
Actinobacterial isolate UST-3 was inoculated in production media 
and incubated for 5 days at 28°C. After incubation, the cultures were 
centrifuged at 10,000 rpm for 15 minutes, and the supernatant was 
collected for extract production. Inoculums of fungal pathogens (0.1 ml) 
were spread on the plates, and 100 µl of crude extract (20-200 µg/ml) 
was loaded in different wells to evaluate the antifungal activity against 
A. niger and A. flavus. Plates were incubated for 24 hrs at 37°C. After 
24 hrs, plates were checked for zone of inhibition [21].
Solvent extraction
Solvent extract of the bioactive compound was done using four different 
solvent such as butanol, ethyl acetate, hexane, and chloroform. The 
potential actinobacterial isolate UST-3 was inoculated in production 
media and incubated at 37°C for 7 days. After incubation period, the 
broth was centrifuged at 1000 rpm for 15 minutes and supernatant 
was collected. To the collected supernatant, equal volume of various 
solvent was added separately and kept in a rotary shaker for 24 hrs 
to extract the active compound. The extracted compound from each 
solvent was then tested for their activity against S. typhi and A. niger by 
agar well diffusion method. After incubation, the zone of inhibition was 
measured [24].
Identification of potential marine actinobacterial strains
Identification of the potential isolates showing good antimicrobial 
and antioxidant activity was done using the key of Nonomura [25] 
and methods of Shirling and Gottlieb [26]. Along with this species 
level identification was also confirmed using cell wall composition 
analysis and by micromorphological studies [27,28]. Finally, the 
complete identification was done using molecular characterization 
based on 16S rRNA sequencing (Yaazh Xenomics, Chennai, Tamil Nadu, 
India). Bacterial genomic DNA was isolated using the InstaGeneTM 
Matrix Genomic DNA isolation Kit. The fragments were amplified 
bi-directionally using the forward (5′-AGAGTTTGATCMTGGCTCAG-3′) 
and reverse (5′-TACGGYTACCTTGTTACGACTT-3′) primers (MJ Research 
Peltier Thermal Cycler). The sequence was analyzed by ABI 3730xl 
capillary DNA sequencer (ABI Prism 310 Genetic Analyzer, Tokyo, 
Japan). Finally, the sequence was observed for similarity using NCBI 
BLAST similarity tool.
Statistical analysis
Using two-way analysis of variance values were analyzed between 
groups of same or different dpi. All values are shown as the 
mean±standard deviation. The significance of the differences between 
the mean values was determined using Student’s t-test. For all statistical 
analysis, *p<0.05 were considered significant.
RESULTS AND DISCUSSION
Isolation of marine Actinobacteria
Isolation of marine Actinobacteria was done on actinobacterial 
isolation agar, starch casein agar, and Kuster’s agar. The result 
obtained in this study reveals that the salt pan sediment samples are 
rich in actinobacterial population. From the collected samples, a total 
of eight actinobacterial colonies were isolated (Fig. 1). Considering 
the total number of isolates, the maximum number were isolated 
on actinobacterial isolation agar (4), followed by starch casein 
agar (2) and Kuster’s agar (2). The isolates were identified using 
culture characteristics as mentioned in ISP manual. All eight isolates 
were belonging to the genera Streptomyces sp. In a previous study, eight 
actinobacterial colonies were isolated on Actinomycetes isolation agar 
from Andaman and Nicobar Islands sediment samples [29]. A total of 
21 actinobacterial colonies were isolated on Actinomycetes isolation 
agar from the marine sediments isolated from Mahabalipuram sea 
shore [30]. In our study, also out of eight actinobacterial colonies four 
were isolated on Actinomycetes isolation agar followed by starch casein 
agar and Kuster’s agar.
Fig. 1: Potential Actinobacterial isolated from Kanyakumari 
marine sediments
114
Asian J Pharm Clin Res, Vol 10, Issue 9, 2017, 112-116
 Shubha et al. 
Antibacterial activity of actinobacterial extract
The bioactive potential of all eight isolates was evaluated by testing 
their antibacterial potential against Gram-positive and Gram-negative 
bacteria. Among eight only one isolate UST-3 showed antimicrobial 
activity against all test pathogens. Cell-free supernatant of UST-3 
showed maximum inhibition against S. typhi with a zone of inhibition 
of 22 mm, followed by K. pneumoniae (16 mm) and E. coli (14 mm). 
The antibacterial profile shown by isolate UST-3 is shown in Fig. 2. The 
extract showed maximum activity at a dose of 200 µg/ml against all 
test pathogens. In a previous report marine Streptomyces sp. isolated 
from Royapuram, Muttukadu and Mahabalipuram sea shore showed 
activity < 13 mm against many clinical bacterial pathogens [30]. In 
another study marine Streptomyces sp. isolated from the southeast 
coast of India, Ramanathapuram, Sethu Karai, showed every good 
activity against clinical pathogens such as S. aureus, S. typhi and 
E. coli with a zone of inhibition above 20 mm. Maximum activity was 
shown against S. typhi with an inhibition zone of 27 mm [31]. Hence, 
our study is in accordance with the previous reports, and also UST-3 
showed similar and better results when compared with the available 
reports.
Antifungal activity of actinobacterial extract
Isolate UST-3 showed good antifungal activity against A. niger and 
A. flavus. Cell-free supernatant of UST-3 showed a maximum zone of 
inhibition (20 mm) against A. niger at a dose of 100 µg/ml followed 
by 15 mm of inhibition at a dose of 80 µg/ml. Similarly, UST-3 showed 
maximum activity against A. flavus (14 mm) at a dose of 100 µg/ml 
followed by 80 µg/ml with a zone of inhibition of 6 mm (Fig. 3). In a 
previous study marine Streptomyces sp. isolated from marine sediments 
of Ennore, Chennai, Tamil Nadu, showed antifungal activity against 
A. niger and A. flavus with a zone of inhibition of 25 mm and 10 mm, 
respectively [32]. Similarly, in another study antifungal activity of 
against A. niger with a zone of inhibition of 19 mm was reported using 
the crude extract of Streptomyces variabilis isolated from Thottada 
marine sediments, Kannur, Kerala [33]. In our study, also active isolate 
UST-3 showed the best activity against A. niger.
Screening using solvent extracted compound
In primary screening potential marine actinobacterial isolates UST-3 
was selected for further studies, i.e., solvent extraction method. The 
isolate UST-3 showed a maximum zone of inhibition (27 mm) using 
ethyl acetate as solvent against the test organism S. typhi (Fig. 4). 
Similarly, UST-3 showed a maximum zone of inhibition (22 mm) using 
hexane as solvent against the test organism A. niger (Fig. 5). Here in 
this study, ethyl acetate and hexane was found as the best solvent for 
extraction of antibacterial and antifungal compounds from marine 
Actinobacteria. Ethyl acetate was reported as a suitable solvent for 
extraction of bioactive compounds from marine Actinobacteria [34], but 
in our study along with ethyl acetate, hexane also showed good active 
compound extraction ability.
Identification of potential isolate UST-3
Using 16S rRNA sequencing the potential isolate was identified as 
S. variabilis. The primary identification of potential strains done 
using the key of Nonomura, micromorphological studies and cell wall 
composition analysis also showed similar results (Table 1). Isolate 
UST-3 formed an extensively branched substrate mycelium which 
carried a recti flexible and smooth surface (Figs. 6 and 7). Potential 
isolate showed 99% of similarity with S. variabilis in the blast search 
analysis. The 16S rRNA sequencing of potential strains was confirmed 
that it occupies a distinctive phylogenetic position with the radiation, 
including representatives of the family using neighbor-joining tree. 
Potential strain was submitted in NCBI as S. variabilis-VITUMVB03.
Fig. 2: Antibacterial activity of potential isolate UST-3 against 
clinical pathogens at 200 μg/ml dose
Fig. 3: Antifungal activity of potential isolate UST-3 against clinical 
pathogens at 100 μg/ml dose
Fig. 5: Antifungal activity of potential isolate UST-3 against 
Aspergillus niger using different solvents
Fig. 4: Antibacterial activity of potential isolate UST-3 against 
Salmonella typhi using different solvents
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CONCLUSION
Marine Actinobacteria are known producers of secondary metabolites; 
they are more miscellaneous and unique with this ability. The 
potential marine actinobacteria isolated in this study showed very 
good antibacterial and antifungal activities at a dose of 200 µg/ml and 
100 µg/ml, respectively. Potential isolate S. variabilis isolated from 
Kanyakumari marine sediments can be used as a promising source for 
the development of antibacterial and antifungal drugs.
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